| Unique ID issued by UMIN | UMIN000060281 |
|---|---|
| Receipt number | R000068957 |
| Scientific Title | Sensory evaluation of the test sample |
| Date of disclosure of the study information | 2026/01/07 |
| Last modified on | 2026/01/07 14:46:49 |
Flavor check test
FCT
Sensory evaluation of the test sample
SE-TS
| Japan |
Not applicable
| Not applicable |
Others
NO
This study aims to evaluate the sensory characteristics of test samples containing organically synthesized saltiness replacers A and B.
Efficacy
To verify the effectiveness of the saltiness-enhancing effect.
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Educational,Counseling,Training
| Food |
When the subjects visit the study site, they will consume a single dose of the test product containing Salt Substitute Substance A or B. They will then verbally report their impressions of taste, texture, and other sensory attributes (sensory evaluation), which will be recorded by the study staff.
| 20 | years-old | <= |
| 80 | years-old | >= |
Male and Female
Male and female subjects aged >=20 years and <80 years at the time of obtaining informed consent.
Subjects who have received a sufficient explanation of the purpose and procedures of this study, have the capacity to provide consent, voluntarily agree to participate after fully understanding the study, and are able to provide written informed consent for participation in this study.
1) Subjects with a known allergy to the investigational product ingredients (wheat, soybeans, or beef).
2) Pregnant or breastfeeding subjects.
3) Subjects who have difficulty consuming the investigational product due to oral/dental disorders, gastrointestinal disorders, or other reasons.
4) Subjects with a history of, or current, serious disease(s) of the liver, kidney, heart, lung, blood, or other organ/system.
5) Subjects with serious concomitant gastrointestinal disease(s) and/or a history of serious gastrointestinal disease.
6) Subjects with a body mass index (BMI) >= 35 kg/m2.
7) Subjects whose habitual alcohol consumption exceeds 60 g/day in terms of pure alcohol equivalent.
8) Subjects who are continuously taking medications that may affect this study.
9) Subjects who are currently receiving medical treatment for a disease and whose treatment is judged to potentially affect the study results or safety.
10) Subjects deemed inappropriate for participation in this study by the principal investigator for any other reason.
20
| 1st name | Mitsuru |
| Middle name | |
| Last name | Tanaka |
Nissin Foods Holdings Co., Ltd.
Global Food Safety Institute
1920001
2100 Tobuki-cho, Hachioji-shi, Tokyo, Japan
0426967833
takahiro.matsuda@nissin.com
| 1st name | Takahiro |
| Middle name | |
| Last name | Matsuda |
Nissin Foods Holdings Co., Ltd.
Global Food Safety Institute
1920001
2100 Tobuki-cho, Hachioji-shi, Tokyo, Japan
0426967833
takahiro.matsuda@nissin.com
Other
Other
Profit organization
Nissin Foods Holdings Co., Ltd.
2100 Tobuki-cho, Hachioji-shi, Tokyo, Japan
0426967833
takahiro.matsuda@nissin.com
NO
| 2026 | Year | 01 | Month | 07 | Day |
Unpublished
Preinitiation
| 2025 | Year | 11 | Month | 20 | Day |
| 2025 | Year | 11 | Month | 21 | Day |
| 2026 | Year | 01 | Month | 20 | Day |
| 2027 | Year | 11 | Month | 19 | Day |
| 2026 | Year | 01 | Month | 07 | Day |
| 2026 | Year | 01 | Month | 07 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000068957